World Hair Congress 2015

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • HairlossAt15
    replied
    Good to see that Kythera is a sponsor of the event

    Leave a comment:


  • macbeth81
    replied
    The Science ZERO Japan video @ 4:10 states Dr. Tsuji is aiming for practical use within 10 years. We can not even get five years anymore, now we have transitioned into decades away.

    Leave a comment:


  • nameless
    replied
    Originally posted by Desmond84
    Whoaaaa guys! They've just released the first draft of abstracts being presented at the congress. Dr Takashi Tsuji is presenting a talk called: "Hair Regeneration as a Future Organ Replacement Regenerative Therapy" on Friday November 20th.

    Another interesting piece of information I found was that Dr Takashi Tsuji also works for RIKEN Centre for Developmental Biology in the Department of Organ Regeneration! Here's the link:



    This centre is actively working to regenerate hair follicles. Let's see if he has anything new to present at this congress <fingers crossed>

    "......as a Future Organ Replacement Regenerative Therapy"

    this is down the road. Probably (you guessed it) 5 years.

    Leave a comment:


  • ar50
    replied
    Originally posted by Desmond84
    Whoaaaa guys! They've just released the first draft of abstracts being presented at the congress. Dr Takashi Tsuji is presenting a talk called: "Hair Regeneration as a Future Organ Replacement Regenerative Therapy" on Friday November 20th.

    Another interesting piece of information I found was that Dr Takashi Tsuji also works for RIKEN Centre for Developmental Biology in the Department of Organ Regeneration! Here's the link:



    This centre is actively working to regenerate hair follicles. Let's see if he has anything new to present at this congress <fingers crossed>
    Whoah thats indeed good news and today I just made an appointment for FUE. Is this method going to make hair transplants obsolete?

    Leave a comment:


  • lacazette
    replied
    Great new Desmond. And with the japan timeline approval, it could go more quickly than we thought!!

    Leave a comment:


  • Arieux
    replied
    @Desmond - that's a good news! Tsuji about 2011 expected about the hair regeneration:
    that it will take five to 10 years to bring the technology to market.
    (http://www.tus.ac.jp/en/initatives/vol02/). We have 2016 soon, so it's high time to present something concrete!

    Leave a comment:


  • Desmond84
    replied
    Whoaaaa guys! They've just released the first draft of abstracts being presented at the congress. Dr Takashi Tsuji is presenting a talk called: "Hair Regeneration as a Future Organ Replacement Regenerative Therapy" on Friday November 20th.

    Another interesting piece of information I found was that Dr Takashi Tsuji also works for RIKEN Centre for Developmental Biology in the Department of Organ Regeneration! Here's the link:



    This centre is actively working to regenerate hair follicles. Let's see if he has anything new to present at this congress <fingers crossed>

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Originally posted by KO1
    So here's the thing. This company was formed primarily to work with Wnt inhibitors in order to treat cancer, and they found their drug candidates via a screen on Pfizer's chemical library. Their whole website, plus the experience of the people involved with the company points to a firm focused on cancer. But for some bizarre reason, a company formed to use Wnt inhibitors to treat cancer is now using Wnt promoters to treat MPB despite none of the scientists having a research interest in MPB?

    Strikes me as odd.
    Well, they have drugs in trials for osteoarthritis, hair loss, and different forms of cancer. Their main focus is the WNT pathway, and in terms of regenerative medicine, all of these issues fall under this umbrella. Kythera, for instance, is interested mostly in medical aesthetics, and their only other drug is one that reduces double-chin fat.

    I'd rather there be a company whose expertise was WNT regarding hair loss, rather than a company whose expertise was hair loss, trying to tinker with the WNT pathway.

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Originally posted by KO1
    So here's the thing. This company was formed primarily to work with Wnt inhibitors in order to treat cancer, and they found their drug candidates via a screen on Pfizer's chemical library. Their whole website, plus the experience of the people involved with the company points to a firm focused on cancer. But for some bizarre reason, a company formed to use Wnt inhibitors to treat cancer is now using Wnt promoters to treat MPB despite none of the scientists having a research interest in MPB?

    Strikes me as odd.
    dble post. deleted

    Leave a comment:


  • KO1
    replied
    Originally posted by Tenma
    Do you think they are not legit?
    So here's the thing. This company was formed primarily to work with Wnt inhibitors in order to treat cancer, and they found their drug candidates via a screen on Pfizer's chemical library. Their whole website, plus the experience of the people involved with the company points to a firm focused on cancer. But for some bizarre reason, a company formed to use Wnt inhibitors to treat cancer is now using Wnt promoters to treat MPB despite none of the scientists having a research interest in MPB?

    Strikes me as odd.

    Leave a comment:


  • Tenma
    replied
    But I have my doubts on the company involved with SM.
    Do you think they are not legit?

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Originally posted by KO1
    I think the only interesting things are Seti, which may not be greater than fin, but it can only help. And SM04554, which is a Wnt agonist, which is implicated in HF morphogenesis and growth. But I have my doubts on the company involved with SM.
    Samumed has backing from pfizer, and they've been able to pay for a massive phase 2. If they claim to be the leading WNT research drug company, and pfizer backs them, then they're probably legit.

    Leave a comment:


  • KO1
    replied
    Originally posted by Pentarou
    Anything else going? Seriously, are we in a worse situation than 2014?

    The mega-treatments like Histogen were always going to be game-changing or stillborn, IMO.
    I think the only interesting things are Seti, which may not be greater than fin, but it can only help. And SM04554, which is a Wnt agonist, which is implicated in HF morphogenesis and growth. But I have my doubts on the company involved with SM.

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Originally posted by Pentarou
    Anything else going? Seriously, are we in a worse situation than 2014?

    The mega-treatments like Histogen were always going to be game-changing or stillborn, IMO.
    Bim is up in the air, CB is in phase 2, Replicel will be in Japan and asian markets by 2018 (they are claiming it's a full cure), Setipiprant (PGD2 blocker backed by Cotsarelis) will be entering phase 2 in Dec/Jan. SM04554 will be finishing phase 2 in September. I'm really excited for SM because of all the "breakthrough discoveries" regarding the WNT pathway and hair loss. All research seems to point to activating the WNT pathway as the best chance for regrowth. They recruited 300 participants (the max for phase 2), and only norwood 4-6. Samumed is also backed by Pfizer, and are the leading company developing drugs for activating or inhibiting the WNT pathway.

    We won't have anything this yr, but 2016 an 2017 should be very good indeed.

    Leave a comment:


  • Pentarou
    replied
    Originally posted by Keki
    cb is alive, bim we don't know till end of year but i don't think it's dead at all and anyway it works, replicel is alive and supported by shiseido, but it's not a home treatment, histogen is 99.9% dead
    Anything else going? Seriously, are we in a worse situation than 2014?

    The mega-treatments like Histogen were always going to be game-changing or stillborn, IMO.

    Leave a comment:

Working...